Top 10 Vero Cell cultured Rabies Vaccine Manufacturers

May 22, 2024

Vero cell cultured Rabies vaccine is a safe and effective way to protect against this deadly virus. By using Vero cells, a type of monkey kidney cell, to grow the vaccine virus, the risk of allergic reactions is minimized. This vaccine has been proven to be highly immunogenic and is recommended for both pre-exposure and post-exposure prophylaxis. Trust in Vero cell cultured Rabies vaccine to keep you and your loved ones safe from rabies.

Serum Institute of India
Bharat Biotech
Changchun Zhuoyi Biological Co., Ltd
GlaxoSmithKline

Serum Institute of India

Establishment time : The Serum Institute of India is a renowned vaccine manufacturer established in 1966.

website : www.seruminstitute.com

Main Product : Their main products are vaccines, catering to global markets.

Company Profile

The company has a long-standing reputation for innovation and excellence in the field of vaccine production.

Bharat Biotech

Establishment time : Bharat Biotech is a leading biotechnology company headquartered in Hyderabad, India.

website :

Main Product : Bharat Biotech has a large presence in the Indian market and has expanded its reach to global markets as well.

Company Profile

Overall, Bharat Biotech is committed to improving public health and making a positive impact on society through its innovative products and services.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

GlaxoSmithKline

Establishment time : GlaxoSmithKline is a leading global healthcare company with a mission to help people do more, feel better, and live longer.

website :

Main Product : GSK's portfolio includes a wide range of pharmaceuticals, vaccines, and consumer healthcare products.

Company Profile

Overall, GlaxoSmithKline is a trusted and respected company in the healthcare industry, known for its high-quality products and commitment to improving global health.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326